Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets.

Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets.

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year.

Key Criteria for Our Selection are:-

  • Uniqueness of the Technology platform and the ability to scale up commercially in case of positive outcome of products in the pipeline
  • Pipeline and clinical data analysis
  • Marketed product and commercial tie up. Robustness of the Management, financial and business model.

Part 1- Rising Stars in Regenerative Medicine and Stem cell based Cell Therapies-Drugs of the Future
Company Analysis:
CESCA Therapeutics Inc. : Hedging the Risk with Stem Cell Based Devices and Therapies and Global Presence
Figure 1: Products In Pipeline
Table 1: Clinical Development- Critical Limb Ischemia (ClI)Data Key Milestones
cata Therapeutics Inc: Ophthalmic Focus- Macular degenerative conditions- Looking with a New Eye
Figure 1: Market For Age-Related Macular Degeneration (AMD)
Figure 2: Products In The Pipeline
rgenesis: Focus- Diabetes- Tricking your Liver to Make Insulin!
Technology Platform
Figure 1: Schematic Representation Of Making Autologous Insulin Producing (AIP) Cell
Tigenix NV : Exploiting the Adipose Tissue- Multiple Applications of Fat?
Technology Platform
Marketed Products
Figure 1 : Products In Pipeline
Key Milestones
Pluristem Therapeutics Inc: Regenerating and Recycling- Allogenic Therapies from the Placenta
PluriX 3D Technology Platform
Figure 1 : Classification Of Peripheral Arterial Disease Types
Market Opportunity
Key Milestones
Mesoblast: Leader in Regenerative Sapce in Korea- Focusing on International Markets
Technology Platform
Pipeline- Focus on four major areas
Figure 1: Drugs In The Pipeline
Figure 2 : CHFf Discease Classification And Target Patients In PhIII Trial
Figure 3: PhiII Data Of MPC-150 In CHF
Figure 4 : Market Opportunity In Chronic Low Back Pain (CLBP)
Key Milestones
Medipost Co Ltd : Leader in Regenerative Space in Korea- Focusing on International Markets
Marketed and Products in the Pipeline
Key Milestones
Figure 1: Sales By Business Segment
JCR Pharmaceuticals co. Ltd.: First Stem Cell Based Product in Japan for Graft-Versus-Host Disease (GVHD).
Technology Platform
Product in the Pipeline
Key Milestones
Facts and Financials
Table 1 : Pipeline Table
Figure 1: Sales By Business Segments
Japan Tissue Engineering co. Ltd: Building Confidence in Regenerative Medicine- Fuji film Venture from Colors to Regenerative Medicine-
Plat form Focus
Figure 1 : Therapy and Product Focus
Part II-Indian Innovators- Rising Stars:
Table 1: Select new generation innovation /drug discovery Indian companies
Connexios: Maturing Pipeline and Focus on Diabetes/Metabolic Disorders to Drive Visibility
Technology Platform
Therapy Focus—Diabetes/Metabolic Disorder and Non Alcoholic Steatohepatitis (NASH)
Key Milestones
Table 1: Differences Between G-Protein Coupled Receptor Agonists
Table 2: Pipeline Of GPR Agonist For Treatment Of Type 2 Diabetes
Figure 1: Products In Pipeline- Diabetes
Figure 2: Products In Pipeline For NASH
Figure 3: Other Programs
Cellworks : In silico Technology Platform Poised to Deliver- Focus on Personalised Medicine and Cancer
Figure 1 : Simulation Based Personalized Medicine
Figure 2 : Cellworks Therapeutic Programs
Bugworks: In silico Technology platform being applied to Serious Hospital Infections- Need of the hour!
Therapy focus- Serious Hospital Infection
Technology Platform
Figure 1: Drug Development Success For TB
Figure 2 : Going Way Froward
Tergene : Affordable and Second Generation Vaccines- Addressing the Urgent needs of Emerging Markets.
Development Strategy and Status
Figure 1: Sales Of Currently Available Vaccines For Streptococcus Pneumonia
Figure 2: WW Demand Forecast Of Vaccines For Streptococcus Pneumonia
Figure 3: Vaccine Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook